Yanhong Tian, Zhichao Wang, Ju Sun, Jiayun Gu, Xiaojuan Xu, Xuwang Cai
{"title":"猪流行性腹泻病毒的 COE 抗原在枯草杆菌孢子上的表面显示。","authors":"Yanhong Tian, Zhichao Wang, Ju Sun, Jiayun Gu, Xiaojuan Xu, Xuwang Cai","doi":"10.1111/1751-7915.14518","DOIUrl":null,"url":null,"abstract":"<p>Porcine epidemic diarrhoea virus (PEDV) infects pigs of all ages by invading small intestine, causing acute diarrhoea, vomiting, and dehydration with high morbidity and mortality among newborn piglets. However, current PEDV vaccines are not effective to protect the pigs from field epidemic strains because of poor mucosal immune response and strain variation. Therefore, it is indispensable to develop a novel oral vaccine based on epidemic strains. <i>Bacillus subtilis</i> spores are attractive delivery vehicles for oral vaccination on account of the safety, high stability, and low cost. In this study, a chimeric gene CotC-Linker-COE (<i>CLE</i>), comprising of the <i>B</i>. <i>subtilis</i> spore coat gene <i>cotC</i> fused to the core neutralizing epitope CO-26 K equivalent (<i>COE</i>) of the epidemic strain PEDV-AJ1102 spike protein gene, was constructed. Then recombinant <i>B</i>. <i>subtilis</i> displaying the CLE on the spore surface was developed by homologous recombination. Mice were immunized by oral route with <i>B</i>. <i>subtilis</i> 168-CLE, <i>B</i>. <i>subtilis</i> 168, or phosphate-buffered saline (PBS) as control. Results showed that the IgG antibodies and cytokine (IL-4, IFN-γ) levels in the <i>B</i>. <i>subtilis</i> 168-CLE group were significantly higher than the control groups. This study demonstrates that <i>B</i>. <i>subtilis</i> 168-CLE can generate specific systemic immune and mucosal immune responses and is a potential vaccine candidate against PEDV infection.</p>","PeriodicalId":209,"journal":{"name":"Microbial Biotechnology","volume":"17 7","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11218686/pdf/","citationCount":"0","resultStr":"{\"title\":\"Surface display of the COE antigen of porcine epidemic diarrhoea virus on Bacillus subtilis spores\",\"authors\":\"Yanhong Tian, Zhichao Wang, Ju Sun, Jiayun Gu, Xiaojuan Xu, Xuwang Cai\",\"doi\":\"10.1111/1751-7915.14518\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Porcine epidemic diarrhoea virus (PEDV) infects pigs of all ages by invading small intestine, causing acute diarrhoea, vomiting, and dehydration with high morbidity and mortality among newborn piglets. However, current PEDV vaccines are not effective to protect the pigs from field epidemic strains because of poor mucosal immune response and strain variation. Therefore, it is indispensable to develop a novel oral vaccine based on epidemic strains. <i>Bacillus subtilis</i> spores are attractive delivery vehicles for oral vaccination on account of the safety, high stability, and low cost. In this study, a chimeric gene CotC-Linker-COE (<i>CLE</i>), comprising of the <i>B</i>. <i>subtilis</i> spore coat gene <i>cotC</i> fused to the core neutralizing epitope CO-26 K equivalent (<i>COE</i>) of the epidemic strain PEDV-AJ1102 spike protein gene, was constructed. Then recombinant <i>B</i>. <i>subtilis</i> displaying the CLE on the spore surface was developed by homologous recombination. Mice were immunized by oral route with <i>B</i>. <i>subtilis</i> 168-CLE, <i>B</i>. <i>subtilis</i> 168, or phosphate-buffered saline (PBS) as control. Results showed that the IgG antibodies and cytokine (IL-4, IFN-γ) levels in the <i>B</i>. <i>subtilis</i> 168-CLE group were significantly higher than the control groups. This study demonstrates that <i>B</i>. <i>subtilis</i> 168-CLE can generate specific systemic immune and mucosal immune responses and is a potential vaccine candidate against PEDV infection.</p>\",\"PeriodicalId\":209,\"journal\":{\"name\":\"Microbial Biotechnology\",\"volume\":\"17 7\",\"pages\":\"\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2024-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11218686/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Microbial Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1751-7915.14518\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1751-7915.14518","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Surface display of the COE antigen of porcine epidemic diarrhoea virus on Bacillus subtilis spores
Porcine epidemic diarrhoea virus (PEDV) infects pigs of all ages by invading small intestine, causing acute diarrhoea, vomiting, and dehydration with high morbidity and mortality among newborn piglets. However, current PEDV vaccines are not effective to protect the pigs from field epidemic strains because of poor mucosal immune response and strain variation. Therefore, it is indispensable to develop a novel oral vaccine based on epidemic strains. Bacillus subtilis spores are attractive delivery vehicles for oral vaccination on account of the safety, high stability, and low cost. In this study, a chimeric gene CotC-Linker-COE (CLE), comprising of the B. subtilis spore coat gene cotC fused to the core neutralizing epitope CO-26 K equivalent (COE) of the epidemic strain PEDV-AJ1102 spike protein gene, was constructed. Then recombinant B. subtilis displaying the CLE on the spore surface was developed by homologous recombination. Mice were immunized by oral route with B. subtilis 168-CLE, B. subtilis 168, or phosphate-buffered saline (PBS) as control. Results showed that the IgG antibodies and cytokine (IL-4, IFN-γ) levels in the B. subtilis 168-CLE group were significantly higher than the control groups. This study demonstrates that B. subtilis 168-CLE can generate specific systemic immune and mucosal immune responses and is a potential vaccine candidate against PEDV infection.
期刊介绍:
Microbial Biotechnology publishes papers of original research reporting significant advances in any aspect of microbial applications, including, but not limited to biotechnologies related to: Green chemistry; Primary metabolites; Food, beverages and supplements; Secondary metabolites and natural products; Pharmaceuticals; Diagnostics; Agriculture; Bioenergy; Biomining, including oil recovery and processing; Bioremediation; Biopolymers, biomaterials; Bionanotechnology; Biosurfactants and bioemulsifiers; Compatible solutes and bioprotectants; Biosensors, monitoring systems, quantitative microbial risk assessment; Technology development; Protein engineering; Functional genomics; Metabolic engineering; Metabolic design; Systems analysis, modelling; Process engineering; Biologically-based analytical methods; Microbially-based strategies in public health; Microbially-based strategies to influence global processes